[New therapeutic strategy for malignant lymphoma targeting cell surface antigens].
Taji
H
H
Morishima
Y
Y
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20